Is the Research Enterprise in Decline? (Part 2)
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? […]
General Biotechnology, Guest content
Guest content
General Biotechnology, Guest content
Biotechnology in Countries Starting with "I" – Part 4: Ireland
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?
Biotechnology in Countries Starting with "I" – Part 4: Ireland Read Post »
General Biotechnology, Guest content
Crowdsourcing in the Biotech world: Innovation and outreach to a wider public
This guest post is from the BiotechBlog Intern, Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin
Crowdsourcing in the Biotech world: Innovation and outreach to a wider public Read Post »
General Biotechnology, Guest content
Association for Molecular Pathology v Myriad: Attorneys React
This guest post is from the BiotechBlog Intern, Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin
Association for Molecular Pathology v Myriad: Attorneys React Read Post »
General Biotechnology, Guest content
After Myriad Oral Argument, Supreme Court Set to Decide Patentability of Isolated Human DNA Molecules
This is a guest post by Morrison & Foerster‘s Marc A. Hearron, James J. Mullen, III and Matthew I. Kreeger. Do you have
General Biotechnology, Guest content
ISO a Scientific Revolution in Cancer Research
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?
Guest content
Will the UK be the Goose that Lays The Golden Access?
This guest post is from the BiotechBlog Intern, Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin
Will the UK be the Goose that Lays The Golden Access? Read Post »
General Biotechnology, Guest content
A Long Road to an Informed Public Opinion
This guest post is from the BiotechBlog Intern, Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin
General Biotechnology, Guest content
Has Bio-Pharma Forgotten to Fail Early?
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?
General Biotechnology, Guest content
Is the Clinical Research Enterprise in Decline?
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s